UAE Anemia Drugs Market Analysis

UAE Anemia Drugs Market Analysis


$ 3999

The UAE Anemia drugs market was valued at $80 Mn in 2022 and is estimated to expand at a CAGR of 9.9% from 2022-30 and will reach $170 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Life Pharma, Neo Pharma, New Bridge Pharmaceuticals, Sahara pharmaceutical, GlaxoSmithKline, GlycoMimetics, and Amgen among others.

ID: IN10AEPH008 CATEGORY: Pharmaceuticals GEOGRAPHY: UAE AUTHOR: Nandini Shah

Buy Now

UAE Anemia Drugs Market Executive Summary

The UAE Anemia drugs market was valued at $80 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.9% from 2022 to 2030 and will reach $170 Mn in 2030. Anaemia is a condition in which the number of red blood cells or the concentration of hemoglobin in them is lower than usual. Haemoglobin is required to carry oxygen, and if you have too few or malformed red blood cells, or not enough hemoglobin, your blood's capacity to carry oxygen to the body's tissues will be reduced. Symptoms include weariness, weakness, dizziness, and shortness of breath, among others. The ideal hemoglobin concentration required to meet physiologic needs varies according to age, gender, elevation, smoking habits, and pregnancy status. Anemia prevalence among women aged 15 to 49 years old was 24.3 percent in 2019, an increase from 23.8 percent in 2010.

The market for anemia drugs in the UAE is being driven by several factors, including an aging population, increasing incidence of chronic diseases such as cancer and kidney disease, and a growing awareness of the importance of early diagnosis and treatment of anemia. In addition, the UAE government has taken steps to improve healthcare infrastructure and increase access to medical treatments, which has also contributed to the growth of the anemia drugs market.

Market Dynamics

Market Growth Drivers

The UAE has a high prevalence of anemia, with estimates suggesting that up to 30% of the population may be affected. This is due to a range of factors, including a lack of iron in the diet, chronic diseases such as cancer and kidney disease, and genetic disorders such as thalassemia. The UAE has an aging population, with the proportion of people over 60 expected to double by 2030. Anemia is more common in older people, so this demographic shift is likely to increase the demand for anemia drugs.

The importance of early detection and treatment of anemia is becoming more widely recognized in the UAE. This is because of greater awareness of the disease and the availability of screening programs to identify people at risk. In recent years, the UAE government has made major expenditures in healthcare infrastructure, including the construction of new hospitals and clinics and the expansion of access to medical treatments. This has made anemia medications and other medical treatments more accessible to individuals. The UAE has a high per capita income, which has resulted in increased healthcare spending. As a result, people are increasingly able to afford treatment for anemia, which has aided growth in the anemia medications industry.

Market Restraints

Anemia medications can be costly, especially for individuals who require long-term treatment. This can make it difficult for certain patients, particularly those without insurance or other types of financial assistance, to buy the necessary prescriptions. While the UAE has an advanced healthcare system, access to anemia medications may be limited in some places or for certain patients. This could be due to prescription shortages, a lack of specialist clinics or medical personnel, or discrepancies in healthcare access based on criteria such as poverty or location. Despite efforts to increase awareness of anemia and its treatment options, there may still be a lack of understanding among some patients and healthcare professionals about the condition and the available treatments. This can lead to delays in diagnosis and treatment, as well as suboptimal management of the condition. Anemia is often associated with other chronic diseases, such as cancer or kidney disease. This can create challenges for healthcare providers seeking to manage anemia in patients with complex medical histories, as well as for patients who may require multiple medications or treatments.

Competitive Landscape

Key Players

  • Life Pharma
  • Neo Pharma
  • New Bridge Pharmaceuticals
  • Sahara pharmaceutical
  • GlaxoSmithKline
  • GlycoMimetics
  • Amgen
  • Julphar
  • Fiza Healthcare

Healthcare Policies and Regulatory Landscape

The regulatory authority responsible for anemia drugs in the UAE is the Ministry of Health and Prevention (MOHAP). The MOHAP is responsible for regulating the pharmaceutical industry in the UAE and ensuring that all medications, including anemia drugs, are safe, effective, and of high quality. The MOHAP has a well-established regulatory framework that governs the registration, import, and distribution of pharmaceutical products in the UAE. All medications, including anemia drugs, must go through a rigorous review and approval process before they can be sold or distributed in the country.

In addition to the MOHAP, other regulatory bodies in the UAE, such as the Dubai Health Authority (DHA) and the Abu Dhabi Health Services Company (SEHA), also play a role in regulating the pharmaceutical industry and ensuring that medications, including anemia drugs, are safe and effective for patients in the UAE. These organizations work closely with the MOHAP to ensure that all medications are appropriately regulated and monitored throughout their lifecycle, from development through to distribution and use by patients.

Reimbursement Scenario

In the UAE, the reimbursement scenario for anemia drugs varies depending on the type of health insurance coverage that a patient has. The majority of the population in the UAE is covered by government-sponsored health insurance plans, including the Dubai Health Authority (DHA) and the Abu Dhabi Health Services Company (SEHA). For patients covered by these plans, anemia drugs are generally covered, but the specific details of coverage may vary depending on the plan and the individual patient's medical history.

 Patients may be required to pay a portion of the cost of the medication, such as a co-pay or deductible, but the remainder of the cost is typically covered by the insurance plan. For patients without insurance coverage, the cost of anemia drugs can be a significant financial burden. In some cases, charitable organizations or government programs may aid help cover the cost of medication for low-income or uninsured patients.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Anemia Drugs Market Segmentation

By Type (Revenue, USD Billion):

  • Iron Deficiency
  • CKD (Chronic Kidney Disease)
  • Sickle Cell
  • Aplastic
  • Others

By Drugs

  • Dietary Supplements
  • Medicines

The types of nutritional supplements are further broken down into iron and vitamin supplements, among other categories, whilst the categories of medicines include antibiotics, hormones (erythropoietin), and chelation therapy (lead poisoning), among others.

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacy
  • Store Pharmacy
  • Online
  • Others

The anemia medicine delivery system in the UAE is complex and multifaceted. To guarantee that their goods are successfully provided to patients in need, pharmaceutical companies must collaborate with a wide range of partners, including hospital and retail pharmacists, distributors, and regulatory authorities.

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 15 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up